D 2008

The influence of LOX/COX inhibitors on the ATRA induced differentiation in neuroblastoma cell lines.

VESELSKÁ, Renata, Martina RÉDOVÁ, Petr CHLAPEK, Tomáš LOJA, Markéta HERMANOVÁ et. al.

Basic information

Original name

The influence of LOX/COX inhibitors on the ATRA induced differentiation in neuroblastoma cell lines.

Edition

Athens, International Journal of Mol. Medicine 22 (Sup. 1) - the 13th World Congress on Advances in Oncology and the 11th International Symposium on Molecular Medicine. p. S55, 1 pp. 2008

Publisher

Spandidos Ltd.

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.880

Organization unit

Faculty of Science

ISSN

Keywords in English

neuroblastoma cell lines; caffeic acid; celecoxibe; all-trans retinoic acid; cell differentiation

Tags

International impact, Reviewed
Změněno: 7/4/2009 11:18, prof. RNDr. Renata Veselská, Ph.D., M.Sc.

Abstract

V originále

Study is focused on the detailed examination of the effect of combined application of the LOX/COX inhibitors with ATRA in established neuroblastoma cell lines.

In Czech

Práce je zaměřena na detailní studium vlivu kombinované aplikace inhibitorů LOX/COX a ATRA u stabilizovaných neuroblastomových buněčných linií.

Links

GD204/08/H054, research and development project
Name: Molekulární mechanismy proliferace a diferenciace buněk
Investor: Czech Science Foundation, Molecular mechanisms of the cell proliferation and differentiation
MSM0021622415, plan (intention)
Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
NR9341, research and development project
Name: Modulace antineoplastického efektu retinoidů LOX/COX inhibitory na modelu dětských solidních nádorů: in vitro studie
Investor: Ministry of Health of the CR